Veradermics, Incorporated share price logo

Veradermics, Incorporated

NYSE: MANE

Mid Cap

$104.08

-4.05

(-3.75%)

as on

Veradermics, Incorporated Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $103.27
    $112.48
    downward going graph

    0.78%

    Downside

    8.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Veradermics, Incorporated share price movements today

Previous Close
$108.13
Open
$109.01
Volume
702.7K
Day's Low - High
$103.27 - $112.48

Veradermics, Incorporated Historical Returns

1 Month Return
+ 57.17 %
3 Month Return
+ 143.32 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Veradermics, Incorporated Stock Fundamentals & Key Indicators

Check Veradermics, Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.4B

EPS (TTM)

-2.5962

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-72.06%

Veradermics, Incorporated vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veradermics, Incorporated with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$4.4BNANA0.00%
BUY$39.4B113.59%74.1312.55%
NA$32.2BNA70.468.94%
BUY$109.1B104.61%25.5135.51%
BUY$74.9B40.55%17.4529.65%

Indian Investors' Interest in Veradermics, Incorporated Stock

Investment in Veradermics, Incorporated Shares on INDmoney has grown by 654.54% in the last 30 days, indicating increased investment activity.

Time period: to

Change:654.54% versus previous 30 day period

Search interest for Veradermics, Incorporated Stock has increased by 1255% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1255% versus previous 30 day period

Veradermics, Incorporated Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-5
-22
EBITDA
-5
-
Interest Expense
0
-
Depreciation
-
-
Income Before Tax
-5
-21
Income Tax Expense
-
-
Net Income
-5
-21
Net Profit Margin
0.00%
0.00%

Veradermics, Incorporated Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
Gross Profit
-
-
-
Operating Income
-17
-26
-71
EBITDA
-16
-25
-
Interest Expense
0
0
-
Depreciation
-
-
-
Income Before Tax
-16
-26
-69
Income Tax Expense
-
-
-
Net Income
-16
-26
-69
Net Profit Margin
0.00%
0.00%
0.00%

Veradermics, Incorporated Quarterly Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-21
Operating Cash Flow
-23
Investing Cash Flow
-
Financing Cash Flow
149
Change in Cash
16

Veradermics, Incorporated Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-26
-69
Operating Cash Flow
-23
-71
Investing Cash Flow
-
-
Financing Cash Flow
60
159
Change in Cash
36
-31

Insights on Veradermics, Incorporated

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MANE stock has moved up by 51.5%

About Veradermics, Incorporated

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.
OrganisationVeradermics, Incorporated
Headquarters470 James Street, New Haven, CT, United States, 06513
IndustryBiotechnology
CEODr. Reid Waldman M.D.
E-voting on sharesClick here to vote

Key Management of Veradermics, Incorporated

Name

Title

Dr. Timothy Durso M.D.

Chief Technical Officer

Mr. Michael V. Greco J.D.

General Counsel & Secretary

Mr. Karl Pruss

Senior Director of Manufacturing Sciences & Technology

Mr. Mark Neumann

Chief Commercial & Strategy Officer

Dr. Michael Smolinski Ph.D.

Vice President of Development & Scientific Operations

Dr. Reid Waldman M.D.

CEO & Director

Mr. Michael Murphy R.Ph.

VP of Project & Program Management of Business Technology and Chief of Staff

Mr. Aron Shapiro

Vice President of Clinical Development & Regulatory Affairs

Mr. Brian Trautman

Director of CMC Project Management

Ms. Barbara Szymaszek

Director of Clinical Operations

FAQs

What is Veradermics, Incorporated share price today?

Veradermics, Incorporated share price today is $104.08 as on at the close of the market. Veradermics, Incorporated share today touched a day high of $112.48 and a low of $103.27.

What is the 52 week high and 52 week low for Veradermics, Incorporated share?

Veradermics, Incorporated share touched a 52 week high of $ on and a 52 week low of $ on . Veradermics, Incorporated stock price today i.e. is closed at $104.08,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Veradermics, Incorporated's market capitalisation today?

Veradermics, Incorporated market capitalisation is $0.00T as on .

How to invest in Veradermics, Incorporated Stock (MANE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veradermics, Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veradermics, Incorporated Shares that will get you 0.0144 shares as per Veradermics, Incorporated share price of $104.08 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Veradermics, Incorporated Stock (MANE) from India?

Indian investors can start investing in Veradermics, Incorporated (MANE) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Veradermics, Incorporated stock (as per the Rupee-Dollar exchange rate as on ). Based on Veradermics, Incorporated share’s latest price of $104.08 as on May 13, 2026 at 1:29 am IST, you will get 0.0961 shares of Veradermics, Incorporated. Learn more about fractional shares .